首页> 外文OA文献 >Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

【2h】

Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

机译：与2型糖尿病的GLP-1受体激动剂相比，心动物和其他糖尿病与SGLT-2抑制剂相关的结果：全国性观察研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Moa Lugner; Naveed Sattar; Mervete Miftaraj; Jan Ekelund; Stefan Franzén; Ann-Marie Svensson; Björn Eliasson;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study [J] . Moa Lugner, Naveed Sattar, Mervete Miftaraj, Cardiovascular Diabetology . 2021,第1期

机译：与2型糖尿病患者的GLP-1受体激动剂相比，心刺突和其他糖尿病相关结果：全国性观察研究
2. Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis [J] . Takayuki Yamada, Mako Wakabayashi, Abhinav Bhalla, Cardiovascular Diabetology . 2021,第1期

机译：具有SGLT-2抑制剂的心血管和肾果糖与2型糖尿病患者GLP-1受体激动剂，慢性肾病：系统审查和网络元分析
3. Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists [J] . Bonaventura A., Carbone S., Dixon D. L., Journal of Internal Medicine . 2019,第1期

机译：减少2型糖尿病心血管疾病的药理策略：专注于SGLT-2抑制剂和GLP-1受体激动剂
4. Treatment of Diabetes and Obesity by Rationally Designed Peptide Agonists Functioning at Multiple Metabolic Receptors [C] . Noushafarin Khajavi, Heike Biebermann, Matthias Tschop, ESPE Advanced Seminar in Developmental Endocrinology . 2017

机译：通过在多种代谢受体中起作用的合理设计肽激动剂治疗糖尿病和肥胖症
5. Diabetes Self-Care Management Behaviors and Barriers to Diabetes Care among Patients with Mental Illness and Type 2 Diabetes, Compared to Those with Type 2 Diabetes Only [D] . Olumba, Appolonia Adaku. 2018

机译：糖尿病在精神疾病和2型糖尿病患者中患糖尿病护理的自我保健管理行为和障碍，与2型糖尿病的患者相比
6. Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study [O] . Moa Lugner, Naveed Sattar, Mervete Miftaraj, 2021

机译：与2型糖尿病的GLP-1受体激动剂相比心动物和其他糖尿病与SGLT-2抑制剂相关的结果：全国性观察研究
7. Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis [O] . Takayuki Yamada, Mako Wakabayashi, Abhinav Bhalla, 2021

机译：患有SGLT-2抑制剂的心血管和肾果剂与2型糖尿病患者的GLP-1受体激动剂和慢性肾病：系统审查和网络META分析

Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

著录项

引文网络

相似文献

相关主题

期刊订阅